CLINICAL TRIALS PROFILE FOR ACETIC ACID 0.25% IN PLASTIC CONTAINER

All Clinical Trials for Acetic Acid 0.25% In Plastic Container

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003697 ↗	Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors	Completed	University of Glasgow	Phase 1	1995-10-01	RATIONALE: Dimethylxanthenone acetic acid may stop the growth of cancer cells by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of dimethylxanthenone acetic acid in treating patients with solid tumors that have not responded to previous therapy.
NCT00044213 ↗	Trial to Assess Chelation Therapy (TACT)	Completed	National Center for Complementary and Integrative Health (NCCIH)	Phase 3	2003-09-01	The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
NCT00044213 ↗	Trial to Assess Chelation Therapy (TACT)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	2003-09-01	The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
NCT00044213 ↗	Trial to Assess Chelation Therapy (TACT)	Completed	Mt. Sinai Medical Center, Miami	Phase 3	2003-09-01	The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
NCT00051545 ↗	Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma	Terminated	LEO Pharma	Phase 3	1999-11-01	To evaluate the efficacy of Seocalcitol in prolonging time to relapse following intended curative resection or percutaneous ablative treatment, i.e. percutaneous ethanol injection(s), percutaneous acetic acid injection(s), percutaneous microwave coagulation therapy, or percutaneous radiofrequency ablation for hepatocellular carcinoma (HCC).

Clinical Trial Conditions for Acetic Acid 0.25% In Plastic Container

Condition Name

Condition Name for Acetic Acid 0.25% In Plastic Container
Intervention	Trials
Cervical Cancer	3
Unspecified Adult Solid Tumor, Protocol Specific	3
Extensive Stage Small Cell Lung Cancer	2
Hepatic Encephalopathy	2

Condition MeSH

Condition MeSH for Acetic Acid 0.25% In Plastic Container
Intervention	Trials
Neoplasms	5
Uterine Cervical Neoplasms	4
Diabetes Mellitus	4
Carcinoma	4

Clinical Trial Locations for Acetic Acid 0.25% In Plastic Container

Trials by Country

Trials by Country for Acetic Acid 0.25% In Plastic Container
Location	Trials
United States	51
Egypt	9
Canada	8
Italy	7
United Kingdom	5

Trials by US State

Trials by US State for Acetic Acid 0.25% In Plastic Container
Location	Trials
California	6
Texas	5
New York	4
Florida	3
New Jersey	3

Clinical Trial Progress for Acetic Acid 0.25% In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Acetic Acid 0.25% In Plastic Container
Clinical Trial Phase	Trials
Phase 4	10
Phase 3	6
Phase 2/Phase 3	3

Clinical Trial Status

Clinical Trial Status for Acetic Acid 0.25% In Plastic Container
Clinical Trial Phase	Trials
Completed	36
Unknown status	11
Recruiting	6

Clinical Trial Sponsors for Acetic Acid 0.25% In Plastic Container

Sponsor Name

Sponsor Name for Acetic Acid 0.25% In Plastic Container
Sponsor	Trials
National Cancer Institute (NCI)	7
M.D. Anderson Cancer Center	4
Digna Biotech S.L.	3

Sponsor Type

Sponsor Type for Acetic Acid 0.25% In Plastic Container
Sponsor	Trials
Other	94
Industry	15
NIH	10